Clinical Dilemmas in Primary Liver Cancer (eBook)
244 Seiten
Wiley (Verlag)
978-1-119-96217-5 (ISBN)
Professor Roger Williams CBE, runs the Institute of Hepatology at UCL, and is a twice former president of EASL. He has authored an incredible 2100 journal articles. Despite advancing years, he is still actively involved in clinical research-340 articles in the past ten years, and analysis by ISI shows him to be one of the most influential researchers in his field. The award of a CBE for services to medicine recognised his major contribution to the study of liver disorders over 25 years including leading the team who performed the first ever liver transplant in the UK. Prof Williams has had many awards, medals, honorary fellowships, and in 2006 was included by HRH The Queen in a celebration at Buckingham Palace to honour those who continue to contribute to public service beyond the age of 65yrs. He was made a Fellow of King's College London in 1992 and an Honorary Fellowship from UCL was conferred on him in 2008, in recognition of his distinguished career and outstanding service to UCL. Professor Simon Taylor-Robinson joined the Department of Medicine at Imperial College London in 1997, having previously been Senior Registrar in Gastroenterology and Hepatology at Hammersmith Hospital. He was awarded the Sir Francis Avery Jones Gold Medal by the British Society of Gastroenterology in 1999 and the Young Investigator Award of the Liver Section of the European Gastroenterology Association in 1997. He is currently Director of the Imperial Clinical Research Facility at St Mary's Hospital, London.
List of Contributors, vii
Preface, x
Part 1: Learning from a Worldwide Perspective
1 Are patterns and prevalence changing?, 3
Hashem B. El-Serag
2 Why is the tumour different in Africa?, 11
Nimzing G. Ladep
3 Control by vaccination: Asian and Taiwan experience, 18
Jia-Horng Kao
4 The view from the United Kingdom, 24
Shahid A. Khan, Mireille B. Toledano, Abigail Zabron, Mehtan Ahmed, and Simon D. Taylor-Robinson
5 The view from the United States, 29
Hitoshi Maruyama and Arun J. Sanyal
6 New challenges of the NAFLD and HIV epidemics, 35
Quentin M. Anstee and Janice Main
Part 2: Influence of Tumour Characteristics
7 Controversies in pathology, 45
Tania Roskams
8 Not to forget the unusual tumour, 53
Bernard C. Portmann
9 What can be learned from molecular diagnostic techniques and genetic signatures?, 60
Tariq Moatter and Saeed Hamid
Part 3: Complexities of Patient Assessment and Scoring Systems
10 Looking after the liver as well as the tumour, 67
Roger Williams
11 Comparative performances of staging systems for hepatocellular cancer: early HCC considerations, 75
Peter D. Peng and Timothy M. Pawlik
12 Rival scoring systems: do they offer more?, 81
Angelo Sangiovanni and Massimo Colombo
13 Is it possible to detect early lesions effectively?, 91
Ryota Masuzaki and Masao Omata
14 What is the value of country-based surveillance programmes?, 97
Peter Ott
Part 4: Choice of Radiological Diagnostic Technique
15 Computed tomography or magnetic resonance imaging for the diagnosis of hepatocellular carcinoma, 107
Wladyslaw Gedroyc
16 Is Microbubble ultrasound useful?, 114
Adrian Lim
17 Value of PET scanning, 118
Tara D. Barwick, Imene Zerizer, and Adil Al-Nahhas
Part 5: Can Treatment be Tailored to the Patient?
18 Who could benefit from chemoembolisation?, 127
Gisele N'Kontchou, Olivier Seror, and Michel Beaugrand
19 Are drug-eluting beads worth using?, 136
Christopher N. Hacking and Pradesh Kumar
20 What is the future of image-guided radiofrequency ablation for hepatocellular carcinoma?, 142
Riccardo Lencioni
21 Alternative ablation techniques for hepatocellular carcinoma, 149
John Karani
22 Justification for sorafenib and chemotherapy, 154
Philip J. Johnson
23 When to consider surgery?, 160
Emmanuel Melloul, Mickael Lesurtel, and Pierre-Alain Clavien
24 Transplant considerations, 168
Myron Schwartz
Part 6: What Does the Future Hold?
25 Dipstick markers for diagnosis: feasible or not?, 179
Mohamed I.F. Shariff and Simon D. Taylor-Robinson
26 Targeted gene therapy for hepatocellular carcinoma: a reality?, 184
Christopher Binny, Marco Della Peruta, and Amit C. Nathwani
27 Is immune modulation a possibility?, 191
Tim F. Greten and Firouzeh Korangy
28 Systemic therapy for hepatocellular carcinoma: future directions, 199
Daniel H. Palmer, Matthew E. Cramp
Index, 212
Colour plate section can be found facing page 86
"This book is a useful introduction to HCC."
(Gastroenterology, 1 August 2012)
Erscheint lt. Verlag | 24.10.2011 |
---|---|
Reihe/Serie | Clinical Dilemmas |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Allgemeines / Lexika |
Medizinische Fachgebiete ► Innere Medizin ► Gastroenterologie | |
Medizinische Fachgebiete ► Innere Medizin ► Hepatologie | |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
Schlagworte | Gastrointestinal surgery • Hepatologie • hepatology • Magen-Darm-Chirurgie • Medical Science • Medizin • Oncology & Radiotherapy • Onkologie u. Strahlentherapie |
ISBN-10 | 1-119-96217-X / 111996217X |
ISBN-13 | 978-1-119-96217-5 / 9781119962175 |
Haben Sie eine Frage zum Produkt? |
Größe: 10,9 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich